Market Cap ₹27992 Cr.
Stock P/E -16.6
P/B 1
Current Price ₹1241.5
Book Value ₹ 1194.4
Face Value 2
52W High ₹1251.6
Dividend Yield 0.81%
52W Low ₹ 736.6
Piramal Enterprises Limited (PEL) is an India-based company this is engaged in various business, consisting of financial services and pharmaceuticals. PEL's monetary services offer various financial products and solutions, with wholesale and retail financing. The wholesale lending business gives financing to real estate builders, in addition to corporate. Within retail lending, PEL is engaged in constructing a multi-product platform and offers domestic loans, loans for small organizations and loans for working capital to its clients. The Company offers India Resurgence Fund (IndiaRF), the distressed asset investment platform, which invests in equity and/or debt across non-real estate sectors. Its monetary offerings additionally encompass opportunity belongings and investments in Shriram Group. PEL has a differentiated enterprise model this is different across three segments: Contract Development and Manufacturing Organization (CDMO), Complex Hospital Generics (CHG), and India Consumer Healthcare.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 2161 | 1894 | 2811 | 2132 | 2878 | 2193 | 2476 | 2473 | 2123 | 2288 |
Other Income | 23 | 63 | 55 | 11 | 21 | 12 | 71 | 55 | 23 | 87 |
Total Income | 2184 | 1956 | 2867 | 2143 | 2899 | 2205 | 2546 | 2528 | 2145 | 2375 |
Total Expenditure | 579 | 3783 | 1818 | 1318 | 1158 | 1083 | 1270 | 2840 | 762 | 936 |
Operating Profit | 1606 | -1827 | 1049 | 825 | 1741 | 1123 | 1276 | -312 | 1384 | 1439 |
Interest | 1044 | 1000 | 959 | 991 | 1042 | 1032 | 1103 | 1167 | 1196 | 1305 |
Depreciation | 25 | 27 | 30 | 41 | 37 | 38 | 41 | 712 | 51 | 55 |
Exceptional Income / Expenses | 7614 | 452 | 0 | 0 | 0 | -64 | -3540 | 1518 | 104 | 77 |
Profit Before Tax | 8152 | -2402 | 59 | -207 | 661 | -12 | -3408 | -673 | 240 | 156 |
Provision for Tax | 145 | -694 | -3432 | 2 | 173 | 11 | -958 | -821 | 66 | 27 |
Profit After Tax | 8006 | -1708 | 3491 | -209 | 488 | -22 | -2450 | 148 | 174 | 129 |
Adjustments | 149 | 172 | 54 | 13 | 21 | 71 | 73 | -11 | 8 | 34 |
Profit After Adjustments | 8155 | -1536 | 3545 | -196 | 509 | 48 | -2378 | 137 | 181 | 163 |
Adjusted Earnings Per Share | 341.7 | -64.4 | 148.6 | -8.2 | 21.3 | 2.1 | -105.8 | 6.1 | 8.1 | 7.2 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 4503 | 5123 | 6381 | 8547 | 10639 | 11883 | 13068 | 12809 | 7726 | 8934 | 10020 | 9360 |
Other Income | 225 | 255 | 252 | 234 | 264 | 314 | 500 | 364 | 272 | 1160 | 892 | 236 |
Total Income | 4728 | 5377 | 6633 | 8781 | 10903 | 12197 | 13569 | 13173 | 7998 | 10095 | 10912 | 9594 |
Total Expenditure | 3868 | 4238 | 4704 | 5048 | 5484 | 5021 | 6810 | 5345 | 2014 | 8395 | 7028 | 5808 |
Operating Profit | 860 | 1140 | 1929 | 3733 | 5419 | 7175 | 6758 | 7828 | 5984 | 1700 | 3884 | 3787 |
Interest | 1050 | 511 | 959 | 2031 | 2978 | 4100 | 5321 | 4209 | 4282 | 4041 | 4400 | 4771 |
Depreciation | 247 | 290 | 255 | 382 | 477 | 401 | 520 | 561 | 74 | 123 | 829 | 859 |
Exceptional Income / Expenses | 1 | 2696 | 46 | -10 | 0 | -452 | 0 | 59 | -153 | 7976 | -2087 | -1841 |
Profit Before Tax | -435 | 3035 | 954 | 1310 | 1964 | 2542 | 1407 | 3456 | 2068 | 5900 | -3278 | -3685 |
Provision for Tax | 63 | 345 | 50 | 228 | -2876 | 852 | 1960 | 2043 | 406 | -4068 | -1595 | -1686 |
Profit After Tax | -498 | 2690 | 905 | 1082 | 4840 | 1690 | -553 | 1413 | 1662 | 9969 | -1684 | -1999 |
Adjustments | -4 | 160 | 0 | 170 | 281 | -223 | 577 | -81 | 261 | 0 | 0 | 104 |
Profit After Adjustments | -501 | 2850 | 905 | 1252 | 5121 | 1467 | 24 | 1332 | 1923 | 9969 | -1684 | -1897 |
Adjusted Earnings Per Share | -28.2 | 160.3 | 50.9 | 70.4 | 277.4 | 77.6 | 1.1 | 59.1 | 80.6 | 417.7 | -74.9 | -84.4 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 12% | -8% | -3% | 8% |
Operating Profit CAGR | 128% | -21% | -12% | 16% |
PAT CAGR | -117% | NAN% | NAN% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 36% | -22% | -5% | 5% |
ROE Average | -6% | 10% | 6% | 9% |
ROCE Average | 1% | 7% | 8% | 9% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 9321 | 11736 | 12948 | 14883 | 26562 | 27224 | 30572 | 34018 | 35489 | 31059 | 26557 |
Minority's Interest | 0 | 29 | 0 | 13 | 12 | 9 | 0 | 1121 | 1348 | 0 | 0 |
Borrowings | 2680 | 3787 | 7474 | 14496 | 24221 | 27033 | 20306 | 28097 | 52329 | 45079 | 46142 |
Other Non-Current Liabilities | 4030 | 4030 | 4286 | 4280 | 1135 | 2000 | 4148 | 6066 | 6384 | 3879 | 2486 |
Total Current Liabilities | 9490 | 5694 | 10542 | 18962 | 22479 | 31213 | 23673 | 13873 | 11249 | 9520 | 11767 |
Total Liabilities | 25521 | 25276 | 35250 | 52634 | 74409 | 87480 | 78699 | 83175 | 106799 | 89537 | 86952 |
Fixed Assets | 6191 | 7065 | 7525 | 9973 | 10726 | 11197 | 6415 | 6563 | 7798 | 953 | 832 |
Other Non-Current Assets | 14958 | 12847 | 23070 | 33498 | 51117 | 63892 | 56170 | 56219 | 34233 | 31780 | 21484 |
Total Current Assets | 4372 | 5364 | 4655 | 9163 | 12566 | 12390 | 16113 | 20393 | 64768 | 54526 | 62929 |
Total Assets | 25521 | 25276 | 35250 | 52634 | 74409 | 87480 | 78699 | 83175 | 106799 | 89537 | 86952 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 269 | 325 | 233 | 227 | 1364 | 2303 | 623 | 2612 | 6748 | 6045 | 3729 |
Cash Flow from Operating Activities | -1604 | -2207 | -6956 | -10057 | -15967 | -11611 | 7516 | 3665 | 8443 | 1378 | 26 |
Cash Flow from Investing Activities | 1483 | 6177 | -604 | -2403 | -1768 | -827 | 7469 | -2772 | -2131 | -407 | -1872 |
Cash Flow from Financing Activities | 126 | -3865 | 7544 | 13570 | 18650 | 10752 | -13019 | 2072 | -6774 | -3287 | 1390 |
Net Cash Inflow / Outflow | 4 | 106 | -16 | 1111 | 916 | -1686 | 1966 | 2964 | -462 | -2316 | -455 |
Closing Cash & Cash Equivalent | 325 | 447 | 227 | 1364 | 2301 | 623 | 2612 | 5582 | 6284 | 3729 | 3274 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -28.2 | 160.31 | 50.89 | 70.44 | 277.38 | 77.65 | 1.07 | 59.07 | 80.58 | 417.71 | -74.94 |
CEPS(Rs) | -14.1 | 167.64 | 65.26 | 82.34 | 288 | 110.63 | -1.46 | 87.51 | 72.76 | 422.86 | -38.04 |
DPS(Rs) | 50.97 | 19.42 | 16.99 | 20.39 | 24.51 | 28 | 14 | 33 | 33 | 31 | 10 |
Book NAV/Share(Rs) | 524.3 | 660.13 | 728.33 | 837.12 | 1438.63 | 1440.68 | 1355.42 | 1508.22 | 1487.08 | 1301.45 | 1178.95 |
Core EBITDA Margin(%) | 14.1 | 17.27 | 26.28 | 40.94 | 48.46 | 57.74 | 47.89 | 58.27 | 73.93 | 6.04 | 29.86 |
EBIT Margin(%) | 13.65 | 69.22 | 29.98 | 39.09 | 46.45 | 55.9 | 51.48 | 59.83 | 82.2 | 111.27 | 11.2 |
Pre Tax Margin(%) | -9.66 | 59.25 | 14.95 | 15.33 | 18.46 | 21.39 | 10.77 | 26.98 | 26.77 | 66.04 | -32.72 |
PAT Margin (%) | -11.05 | 52.52 | 14.18 | 12.66 | 45.49 | 14.22 | -4.23 | 11.03 | 21.52 | 111.58 | -16.8 |
Cash Profit Margin (%) | -5.57 | 58.18 | 18.18 | 17.13 | 49.98 | 17.59 | -0.25 | 15.41 | 22.48 | 112.95 | -8.53 |
ROA(%) | -2.01 | 10.59 | 2.99 | 2.46 | 7.62 | 2.09 | -0.67 | 1.75 | 1.75 | 10.15 | -1.91 |
ROE(%) | -4.96 | 25.55 | 7.33 | 7.78 | 23.36 | 6.28 | -1.91 | 4.37 | 4.78 | 29.96 | -5.85 |
ROCE(%) | 3.3 | 18.7 | 7.93 | 8.96 | 8.52 | 8.63 | 8.63 | 10.5 | 7.73 | 11.59 | 1.4 |
Receivable days | 53.39 | 55.27 | 51.55 | 44.38 | 42.25 | 42.37 | 38.09 | 40.88 | 74.79 | 33.51 | 1.56 |
Inventory Days | 48.4 | 47.28 | 40 | 30.89 | 25.68 | 24.66 | 26.43 | 33.63 | 66.91 | 0 | 0 |
Payable days | 156.43 | 138.11 | 169.39 | 191.06 | 196.95 | 221.73 | 212.31 | 205.92 | 0 | 0 | 0 |
PER(x) | 0 | 5.26 | 19.76 | 26.21 | 8.59 | 34.63 | 881.17 | 29.66 | 27.14 | 1.62 | 0 |
Price/Book(x) | 1.01 | 1.28 | 1.38 | 2.21 | 1.66 | 1.87 | 0.69 | 1.16 | 1.47 | 0.52 | 0.72 |
Dividend Yield(%) | 9.64 | 2.3 | 1.69 | 1.1 | 1.02 | 1.02 | 1.49 | 1.88 | 1.51 | 4.57 | 1.18 |
EV/Net Sales(x) | 4.14 | 4.26 | 5.3 | 7.22 | 8.05 | 8.91 | 4.47 | 5.61 | 13 | 6.84 | 6.81 |
EV/Core EBITDA(x) | 21.64 | 19.16 | 17.52 | 16.54 | 15.81 | 14.76 | 8.65 | 9.18 | 16.79 | 35.95 | 17.57 |
Net Sales Growth(%) | 27.91 | 13.77 | 24.57 | 33.93 | 24.48 | 11.69 | 9.98 | -1.98 | -39.69 | 15.65 | 12.16 |
EBIT Growth(%) | 60.82 | 476.76 | -46.04 | 74.63 | 47.91 | 34.4 | 1.29 | 13.92 | -17.15 | 56.55 | -88.71 |
PAT Growth(%) | -128.77 | 640.76 | -66.37 | 19.61 | 347.28 | -65.09 | -132.75 | 355.35 | 17.65 | 499.71 | -116.89 |
EPS Growth(%) | -120.6 | 668.39 | -68.25 | 38.42 | 293.78 | -72.01 | -98.63 | 5444.46 | 36.42 | 418.36 | -117.94 |
Debt/Equity(x) | 1.02 | 0.62 | 1.26 | 2.05 | 1.66 | 2.06 | 1.38 | 1.16 | 1.56 | 1.6 | 2.02 |
Current Ratio(x) | 0.46 | 0.94 | 0.44 | 0.48 | 0.56 | 0.4 | 0.68 | 1.47 | 5.76 | 5.73 | 5.35 |
Quick Ratio(x) | 0.39 | 0.82 | 0.37 | 0.45 | 0.52 | 0.37 | 0.64 | 1.38 | 5.62 | 5.73 | 5.35 |
Interest Cover(x) | 0.59 | 6.94 | 2 | 1.65 | 1.66 | 1.62 | 1.26 | 1.82 | 1.48 | 2.46 | 0.26 |
Total Debt/Mcap(x) | 1.02 | 0.49 | 0.91 | 0.93 | 1 | 1.1 | 1.99 | 1 | 1.06 | 3.07 | 2.81 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 43.49 | 43.48 | 43.48 | 43.48 | 43.48 | 46.19 | 46.19 | 46.19 | 46.03 | 46.3 |
FII | 34.54 | 32.06 | 31.25 | 28.67 | 26.05 | 19.68 | 17.18 | 16.97 | 16.19 | 14.93 |
DII | 8.14 | 7.86 | 8.06 | 9.59 | 11.92 | 12.05 | 13.02 | 13.19 | 13.35 | 14.94 |
Public | 13.84 | 16.6 | 17.2 | 18.25 | 18.55 | 22.07 | 23.6 | 23.64 | 24.44 | 23.82 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | 10.44 |
FII | 8.24 | 7.65 | 7.46 | 6.84 | 6.22 | 4.42 | 3.86 | 3.81 | 3.65 | 3.37 |
DII | 1.94 | 1.88 | 1.92 | 2.29 | 2.85 | 2.71 | 2.93 | 2.96 | 3.01 | 3.37 |
Public | 3.3 | 3.96 | 4.11 | 4.36 | 4.43 | 4.96 | 5.3 | 5.31 | 5.51 | 5.37 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 23.87 | 23.87 | 23.87 | 23.87 | 23.87 | 22.47 | 22.47 | 22.47 | 22.55 | 22.55 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About